Synthesis and Biological Evaluation of Sparsomycin Analogues
Three series of sparsomycin analogues were prepared and examined for their ability to inhibit DNA or protein synthesis in bone marrow, P388 lymphocytic leukemia, and P815 mastocytoma cells.The compounds of series I and II, distinguished by the inclusion o